Description
-
-
This research formulation includes SLU-PP-332, 5-Amino-1MQ, and BPC-157, provided for non-clinical experimental use only.
-
SLU-PP-332 is investigated as a selective ERR agonist, studied in models involving mitochondrial biogenesis and oxidative metabolism.
-
5-Amino-1MQ is evaluated for its NNMT-inhibiting properties, with research focused on NAD+ pathway modulation and cellular energetics.
-
BPC-157 is included in research on tissue integrity, inflammatory response, and angiogenic repair mechanisms.
-
The blend is frequently used in studies exploring metabolic adaptation, recovery processes, and energy pathway signaling in various laboratory settings.
-







There are no reviews yet.